)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
C4 Therapeutics
C4 Therapeutics (CCCC) investor relations material
C4 Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary29 Apr, 2026
Voting matters and shareholder proposals
Election of three Class III directors to serve until the 2029 Annual Meeting, with nominees Andrew Hirsch, Stephen Fawell, Ph.D., and Utpal Koppikar.
Advisory vote to approve the compensation of named executive officers.
Ratification of KPMG LLP as independent registered public accounting firm for the year ending December 31, 2026.
Approval of an amendment to the 2020 Stock Option and Incentive Plan to include outstanding pre-funded warrants in the share count for the evergreen provision.
Proxies authorized to vote on any other business properly brought before the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director elections and plan amendments.
Executive compensation and say-on-pay
Advisory vote scheduled for shareholder approval of executive officer compensation.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from C4 Therapeutics
- Shareholders to vote on key governance, compensation, and equity plan changes amid clinical progress.CCCC
Proxy filing29 Apr 2026 - Cemsidomide advances in late-stage MM trials, with INN-focused discovery and strong financial runway.CCCCCorporate presentation13 Apr 2026
- Cemsidomide enters late-stage trials with strong funding and MRD-driven regulatory strategy.CCCCGuggenheim Securities Emerging Outlook: Biotech Summit 202611 Apr 2026
- Cemsidomide and CFT8919 advance as best-in-class degraders for MM and NSCLC, with strong pipeline momentum.CCCCCorporate presentation13 Mar 2026
- Cemsidomide advances in global trials, targeting best-in-class efficacy for multiple myeloma.CCCCBarclays 28th Annual Global Healthcare Conference10 Mar 2026
- Cemsidomide advances as a best-in-class myeloma therapy with strong clinical and regulatory momentum.CCCCTD Cowen 46th Annual Health Care Conference3 Mar 2026
- Advancing next-gen degraders for MM, NSCLC, and INN diseases with strong financial backing.CCCCCorporate presentation27 Feb 2026
- Cemsidomide advanced in clinical trials, revenue grew, and cash runway extended to 2028.CCCCQ4 202526 Feb 2026
- Cemsidomide advances to phase two with robust efficacy, strong safety, and global expansion plans.CCCCEvercore ISI 8th Annual HealthCONx Conference3 Feb 2026
Next C4 Therapeutics earnings date
Q1 202613 May, 2026
C4 Therapeutics
Next C4 Therapeutics earnings date
Q1 202613 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage